(R)-Lansoprazole Dexlansoprazole CAS 138530-94-6 Assay 98.0~102.0% (HPLC) Factory

Inkcazelo emfutshane:

Igama leMichiza: (R)-Lansoprazole

Izithethantonye: Dexlansoprazole

CAS: 138530-94-6

Uvavanyo: 98.0~102.0% (HPLC, %w/w)

Imbonakalo: Mhlophe ukuya kuMhlophe-Mhlophe wePowder

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

I-Ruifu Chemical Supply Lansoprazole Intermediates
ILansoprazole CAS 103577-45-3
ILansoprazole Chloride Compound CAS 127337-60-4
(R)-Lansoprazole Dexlansoprazole CAS 138530-94-6

Iipropati zeMichiza:

Igama leMchiza	(R)-Lansoprazole
Izithethantonye	R-(+)-Lansoprazole;Dexlansoprazole;2-[(R)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;T 168390;THATHA 390;Ukungcola kweLansoprazole 14;Ukungcola okuNxulumene neDexlansoprazole 2;(R) -2-[[[3-Methyl-4- (2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl] -1H-Benzimidazole;
Inombolo yeCAS	138530-94-6
Inombolo yeCAT	RF-PI1916
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C16H14F3N3O2S
Ubunzima beMolekyuli	369.36
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Mhlophe ukuya kuMhlophe oMhlophe wePowder
Ukunyibilika	I-Soluble kwi-Dimethylformamide, iphantse inganyibiliki emanzini
Ukucaca kunye nombala wesisombululo	Iyahlangabezana neMfuneko
Ukuchongwa kwe-IR	I-infrared absorption spectrum kufuneka ihambelane nereferensi yento
Ukuchongwa kwe-HPLC	Ixesha lokugcinwa kwencopho ephambili kufuneka lihambelane naleyo yereferensi
Ukujikeleziswa okuthe ngqo	+142.0°～+149.0°
Indawo yokunyibilika	~140.0℃
Isiqulatho samanzi (KF)	<1.00%
Intsalela kwi-Ignition	<0.10%
Ukungcola Okunxulumeneyo	(HPLC)
Ii-nitrogen oxides	<0.10%
Sulfone	<0.40%
Sulfidi	<0.20%
Nakuphi na Okunye Ukungcola Okukodwa	<0.10%
Ukungcola ngokupheleleyo	<0.60%
Ukucoceka kwamehlo (HPLC)	>99.5%
Isivavanyi	98.0~102.0% (HPLC, %w/w, kwisiseko se-anhydrous, i-solvent-free)
Iintsimbi ezinzima	<10ppm
Izinyibilikisi ezishiyekileyo
Toluene	<890ppm
n-Heptane	<5000ppm
I-Endotoxin yebhaktiriya	<2.5EU/mg
Umgangatho woVavanyo	Umgangatho we-USP;Pharmacopoeia yaseTshayina
Ukusetyenziswa	API;I-Proton Pump Inhibitor esebenzayo ngomlomo

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

(R) -Lansoprazole (CAS: 138530-94-6) yiR enantiomer yeLansoprazole, iLansoprazole (AG 1749) yiproton pump inhibitor esebenzayo ngomlomo ekhusela isisu ekuveliseni i-asidi.I-Dexlansoprazole ye-Lansoprazole dextroisomer, luhlobo lwamachiza e-anti peptic ulcer kwi-derivatives ye-benzimidazole endaweni, kwisakhiwo semolekyuli kwi-element fluorine, i-proton pump inhibitors yesibini emva kwe-omeprazole.I-Dexlansoprazole inefuthe lokuthintela ukukhutshwa kwe-asidi yesisu, umphumo ungcono kunezinye iziyobisi (i-Omeprazole, i-Pantoprazole, i-Rebela, i-Tetrazolium) inokuthintela kakhulu ukwenzeka kwesilonda.Ingaphezulu kwe-famotidine okanye i-Omeprazole yomonakalo we-alcohol induced gastric mucosa kunye ne-duodenal ulcer ebangelwa ikakhulu yi-acid hypersecretion.Ukongeza, imveliso inefuthe elifanayo le-anti Helicobacter pylori njengokulungiswa kwe-bismuth, kwaye isetyenziselwa i-reflux esophagitis kunye ne-Zhuo AI syndrome.I-Takeda Pharmaceuticals ifumene imvume ye-dexlansoprazole, i-dual release formulation ye (R) -isomer ye-lansoprazol proton pump inhibitor (PPI) esele ikwimarike, ukusuka kwi-FDA ngoJanuwari 2009. I-Dexlansoprazole ilibaziseka ukukhulula i-capsule ukwenzela ukuba kanye ngosuku, unyango lomlomo. isitshisa esinxulumene nesifo se-reflux ye-non-erosive gastroesophageal (GERD), ukuphiliswa kwe-erosive esophagitis (EE) kunye nokugcinwa kwe-EE ephilileyo.